Brief: Medicamen Biotech Signs Distribution Agreement With XGX Pharma For European Market
08/04/2025 09:14
April 8 (Reuters) - Medicamen Biotech Ltd MEBI.NS: MEDICAMEN BIOTECH LTD - SIGNS DISTRIBUTION AGREEMENT WITH XGX PHARMA FOR EUROPEAN MARKET MEDICAMEN BIOTECH LTD - TO HOLD MARKETING AUTHORIZATION FOR THREE PRODUCTS Source text: ID:nBSE4WX03Q Further company coverage: MEBI.NS ((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Medicamen Biotech
See all newsBrief: Medicamen Biotech Recommends Final Dividend Of 1 Rupee Per Share For FY Ended March 31, 2026
Brief: Medicamen Biotech Gets EU Approval For Registration Of “Paracetamol” From Denmark With XGX Pharma
India's Medicamen Biotech gains on US FDA nod for blood cancer drug
Brief: Medicamen Biotech Approves Allotment Of Shares, Warrants
India's Medicamen Biotech rises after deal with Denmark's XGX Pharma